{"id":253027,"date":"2025-11-09T12:29:06","date_gmt":"2025-11-09T12:29:06","guid":{"rendered":"https:\/\/www.newsbeep.com\/uk\/253027\/"},"modified":"2025-11-09T12:29:06","modified_gmt":"2025-11-09T12:29:06","slug":"hunting-cheap-ai-shares-to-buy-consider-these-2-promising-start-ups","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/uk\/253027\/","title":{"rendered":"Hunting cheap AI shares to buy? Consider these 2 promising start-ups"},"content":{"rendered":"

\"Road<\/p>\n

Image source: Getty Images<\/p>\n

With artificial intelligence (AI) rapidly taking over our daily lives, many investors are wondering which shares to buy to benefit from the boom. It may be too late to get in on overvalued tech giants like Nvidia or Meta. Plus, most smaller AI outfits like Anthropic and DeepMind aren\u2019t publicly traded.<\/p>\n

But there\u2019s still a ton of cheap AI-focused companies trading on the stock market. The trick is identifying the small guys before they take off. So which companies are quietly building groundbreaking AI tech in the background? <\/p>\n

Consider these two lesser-known tech innovators with promising products in the pipeline.<\/p>\n

Tempus AI<\/p>\n

Tempus AI (NASDAQ:TEM<\/a>) is an American health technology company specialising in AI-enabled precision medicine. It aims to make diagnostics and personalised treatment decisions more data-driven and efficient.<\/p>\n

This kind of tech is critically important to patients suffering from terminal diseases like cancer. Just ask founder Eric Lefkofsky, who started the company after his wife was diagnosed with breast cancer.<\/p>\n

The company combines AI and data analytics to provide precision medicine services for oncology, cardiology, radiology, and psychiatric disorders. Beyond just diagnostic, it also focuses on personalised care pathways.<\/p>\n

At $75 a share, it doesn\u2019t look particularly cheap, but it\u2019s down almost 30% from its 52-week high.\u00a0And like many rapidly expanding tech start-ups, it\u2019s yet to turn a profit<\/a>. That makes it hard to value, which is risky. If it keeps racking up debt without turning a profit, it could go bankrupt.\u00a0<\/p>\n

That said, revenue has exploded from $188m to $1.11bn in just five years. So it\u2019s doing something right.<\/p>\n

Encouragingly, major US investment firm<\/a> ARK Invest is optimistic about the company\u2019s prospects. Both its Genomic Revolution ETF and ARK Innovation ETF hold the stock, with weightings of 9.78% and 4.82%, respectively.<\/p>\n

Serve Robotics<\/p>\n

Serve Robotics (NASDAQ:SERV<\/a>) builds autonomous sidewalk delivery robots. Yes, those cute four-wheeled robot boxes that are the postmen of the future. I\u2019m not sure it\u2019s the future I want, but here we are \u2013 so may as well capitalise on the progress.<\/p>\n

The robots use Nvidia\u2019s latest AI combined with groundbreaking Ouster REV7 LiDAR sensors to calculate and navigate optimal delivery routes. They\u2019re designed to handle real-world urban sidewalk environments, navigating potholes, curbs, uneven sidewalks, and pedestrian traffic safely.<\/p>\n

Not only that, their average delivery time is comparable to or faster than human couriers. As I sit here wondering where my pizza delivery is, it\u2019s safe to say these robots will be in high demand.<\/p>\n

Following a commercial partnership with the Uber Eats platform, the company aims to expand deployment of up to 2,000 robots by the end of 2025.<\/p>\n

A key risk, of course, is that a robot goes rogue, injures somebody, and the company gets hit with a massive lawsuit.<\/p>\n

The bottom line<\/p>\n

Tempus\u2019s AI tech looks highly promising, as it continues to expand the boundaries of personalised healthcare. By coupling high-throughput genomics and molecular data with powerful AI tools, it aims to transform patient care globally.<\/p>\n

Meanwhile, Serve Robotics exemplifies a practical, scalable application of AI to provide an everyday service.<\/p>\n

To me, they both look like compelling AI stocks to consider before they become massive household names. And that\u2019s not all \u2013 there are many other eye-catching AI stocks to consider on the market these days.<\/p>\n","protected":false},"excerpt":{"rendered":"Image source: Getty Images With artificial intelligence (AI) rapidly taking over our daily lives, many investors are wondering…\n","protected":false},"author":2,"featured_media":253028,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[554,733,4308,86,56,54,55],"class_list":{"0":"post-253027","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-artificial-intelligence","8":"tag-ai","9":"tag-artificial-intelligence","10":"tag-artificialintelligence","11":"tag-technology","12":"tag-uk","13":"tag-united-kingdom","14":"tag-unitedkingdom"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/253027","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/comments?post=253027"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/253027\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media\/253028"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media?parent=253027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/categories?post=253027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/tags?post=253027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}